Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lees

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Human Molecular Genetics|April 30, 2004
The structure of the tau haplotype in controls and in progressive supranuclear palsyAlan M Pittman, Amanda J Myers, Jaime Duckworth, et al.
The Lancet. Neurology|July 30, 2018
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trialRegina Katzenschlager, Werner Poewe, Olivier Rascol, et al.
Neuroscience Letters|June 30, 2012
Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohortsMichael C Kruer, Reema Paudel, Wendy Wagoner, et al.
Vaccine|July 25, 2022
Genetically detoxified tetanus toxin as a vaccine and conjugate carrier proteinMin-Ju Chang, Morgane Ollivault-Shiflett, Richard Schuman, et al.
Neurodegenerative Disease Management|March 21, 2022
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's diseaseChristine Schofield, K Ray Chaudhuri, Camille Carroll, et al.
Journal of Pharmaceutical Sciences|March 13, 2018
Analytical Comparability Assessments of 5 Recombinant CRM<sub>197</sub> Proteins From Different Manufacturers and Expression SystemsJohn M Hickey, Vishal M Toprani, Kawaljit Kaur, et al.
Acta Neuropathologica|December 11, 2007
MAPT S305I mutation: implications for argyrophilic grain diseaseGabor G Kovacs, Alan Pittman, Tamas Revesz, et al.
Acta Neuropathologica|December 6, 2005
Sporadic four-repeat tauopathy with frontotemporal degeneration, parkinsonism and motor neuron diseaseYue-Shan Piao, Chun-Feng Tan, Keisuke Iwanaga, et al.
Frontiers in Neurology|September 9, 2022
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A <i>post-hoc</i> analysis of BIPARK-I and IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Frontiers in Neurology|November 22, 2021
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A <i>Post-hoc</i> Analysis of BIPARK-I and -IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Human Molecular Genetics|April 30, 2004
The structure of the tau haplotype in controls and in progressive supranuclear palsyAlan M Pittman, Amanda J Myers, Jaime Duckworth, et al.
The Lancet. Neurology|July 30, 2018
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trialRegina Katzenschlager, Werner Poewe, Olivier Rascol, et al.
Neuroscience Letters|June 30, 2012
Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohortsMichael C Kruer, Reema Paudel, Wendy Wagoner, et al.
Vaccine|July 25, 2022
Genetically detoxified tetanus toxin as a vaccine and conjugate carrier proteinMin-Ju Chang, Morgane Ollivault-Shiflett, Richard Schuman, et al.
Neurodegenerative Disease Management|March 21, 2022
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's diseaseChristine Schofield, K Ray Chaudhuri, Camille Carroll, et al.
Journal of Pharmaceutical Sciences|March 13, 2018
Analytical Comparability Assessments of 5 Recombinant CRM<sub>197</sub> Proteins From Different Manufacturers and Expression SystemsJohn M Hickey, Vishal M Toprani, Kawaljit Kaur, et al.
Acta Neuropathologica|December 11, 2007
MAPT S305I mutation: implications for argyrophilic grain diseaseGabor G Kovacs, Alan Pittman, Tamas Revesz, et al.
Acta Neuropathologica|December 6, 2005
Sporadic four-repeat tauopathy with frontotemporal degeneration, parkinsonism and motor neuron diseaseYue-Shan Piao, Chun-Feng Tan, Keisuke Iwanaga, et al.
Frontiers in Neurology|September 9, 2022
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A <i>post-hoc</i> analysis of BIPARK-I and IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Frontiers in Neurology|November 22, 2021
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A <i>Post-hoc</i> Analysis of BIPARK-I and -IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Pageof 19